Stockreport

Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why [Yahoo! Finance]

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com
PDF This clinical-stage company is developing its pipeline candidate, tamibarotene, an oral, selective, retinoic acid receptor alpha or RARa agonist as a frontline treatmen [Read more]